www.joyetv.com

Top quality 4-chloro- Benzo[b]thiophene CAS 66490-33-3  

82

Top quality 4-chloro- Benzo[b]thiophene CAS 66490-33-3

Top quality 4-chloro- Benzo[b]thiophene CAS 66490-33-3: CAS No.: 66490-33-3 Name: 4-chloro- Benzo[b]thiophene MF:  C8H5ClS Brexpiprazole, sold under the brand name Rexulti, is an atypical antipsychotic. It is a dopamine D2 receptor partial agonistand has been described as a "serotonin–dopamine activity modulator" (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. It has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD). The drug was developed by Otsuka and Lundbeck, and is considered to be a successor of Otsuka's top-selling atypical antipsychotic aripiprazole (Abilify). Otsuka's U.S. patent on aripiprazole expired on October 20, 2014; and a generic was approved in April, 2015. Our pro…